# Edesa Biotech, Inc.: Form SCHEDULE 13D/A, filed Mar 2, 2026

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 19:03 ET
- Period: not reported
- Accession: 0000921895-26-000578
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000092189526000578/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000092189526000578/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000092189526000578/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0000921895-26-000578. Last ingested by Listed: Nov 12, 2026, 19:32 ET. No prices; not investment advice.
